These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
    Author: Zhang J, Zheng J, Fang W.
    Journal: Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779.
    Abstract:
    OBJECTIVE: To investigate the correlation between p53 gene mutation and protein expression and discuss the sensitivities of immunohistochemistry and PCR-SSCP in detecting p53 abnormalities in lung cancer. METHODS: Immunohistochemistry, PCR-SSCP, and PCR-sequencing were used. RESULTS: 22 of 30 patients showed p53 mutations by PCR-sequencing. Mutations of 8 patients (36%) located on exon 5, 2(9%) on exon 6, 7 (32%) on exon 7, and 5(23%) on exon 8, respectively. 14 patients (64%) showed missense mutations, and 4(18%) neutral mutations, 3(14%) frameshifts and 1(5%) splice site mutation. In all mutations, G:C-->T:A transversions accounted for 41%(9/22). p53 missense mutations were found in all 10 patients whose immunohistochemistry and PCR-SSCP were both positive. Nine of 10 patients whose PCR-SSCP was positive but immunohistochemistry negative had p53 mutations, including 4 patients with neutral mutations, 3 frameshift mutations, 1 missense mutation, and 1 splice site mutation. In 10 patients whose immunohistochemistry was positive but PCR-SSCP negative, only 3 showed p53 missense mutations. CONCLUSION: Most of p53 mutation sites located on exon 5 and exon 7 in lung cancer of China. Missense mutations and G to T transversions were prevalent. If both PCR-SSCP and immunohistochemistry gave the positive results, p53 missense mutations may be expected.
    [Abstract] [Full Text] [Related] [New Search]